학력

1999. 전남대학교 의과대학 의학과 학사학위 취득

2002. 전남대학교 대학원 의학과 석사학위 취득

2006. 전남대학교 대학원 의학과 박사학위 취득

펼쳐보기

경력

1999. 03. ~ 2000. 02. 전남대학교병원 인턴

2000. 03. ~ 2004. 02. 전남대학교병원 신경외과 전공의

2004. 03. ~ 2007. 08. 화순전남대학교병원 신경외과 전임의, 임상교수

2005. 11. 내시경 뇌수술 연수교육 (독일, 마인쯔)

2006. 11. 아시아태평양 소아신경외과 교육과정 이수 (한국, 인천)

2007. 09. ~ 2011. 08. 전남대학교 의과대학 신경외과 조교수

2009. 09. ~ 11. 뇌종양 수술 연수 (케나다, 토론토대학 연수)

2011. 09. ~ 2016. 08. 전남대학교 의과대학 신경외과 부교수

2014.10 국제소아신경외과학회 연수교육 (일본, 도쿄)

2016. 09 ~ 현재. 전남대학교 의과대학 신경외과 교수

펼쳐보기

경력 중 수상경력

2009.06.24 전남대학교병원 의학연구 학술상

2010.06.20 대한뇌종양학회 최우수논문상

2010.07.24 화순전남대학교병원 젊은 의학자 연구 학술상

2010.10.15 대한신경외과학회 종양 부분 최우수 논문상 (심보성 학술상)

2012.10.18 대한신경외과학회 젊은 신경외과 학술상

2013.05.23 대한소아신경외과학회 최우수논문상 (연세우원학술상)

2015.09.18 대한소아뇌종양학회 아해 우수연구상

2018.03.17 대한신경종양학회 학술상 (BTRT학술지 최우수논문)

2020.09.05 대한신경종양학회 학술대회 최우수 연제상

2020.10.23 대한신경외과학회 종양 부분 최우수 논문상 (심보성 학술상)

펼쳐보기

연구업적

2022. Jung TY, Baek HJ, Kim SK, Lee KH: Staged operations for a hypervascular mixed germ cell tumor with growing teratoma syndrome: a case report. Childs Nerv Syst 38(1):11-16 (2022)

2021. Park SJ, Lim SH, Kim YJ, Moon KS, Kim IY, Jung S, Kim SK, Oh IJ, Hong JH, Jung TY: The tumor control according to radiation dose of gamma knife radiosurgery for small and medium-sized brain metastases from non-small cell lung cancer. J Korean Neurosurg Soc 64(6):983-994 (2021)

2021. Tran TA, Kim YH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY: Branched Multipeptide-Combined Adjuvants Potentially Improve the Antitumor Effects on Glioblastoma. J Immunother 44(4):151-161 (2021)

2021. JK Kim, S Jung, IY Kim, WY Jang, KS Moon, SK Kim, JH Kim & KH Lee, TY Jung.
Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
Clin Transl Oncol 23, 459–467 (2021).

2021. Tran TA, Kim YH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY.
Branched Multipeptide-combined Adjuvants Potentially Improve the Antitumor Effects on Glioblastoma
J Immunother. 2021 Jan 27. doi: 10.1097/CJI.0000000000000359. Online ahead of print.

2020. Kim YH, Tran TA, Duong TH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY.
Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
Hum Vaccin Immunother. 2020 Nov 1;16(11):2840-2848. doi: 10.1080/21645515.2020.1732165. Epub 2020 May 13.

2020. Kim JW, Jung JH, Baek HJ, Kim SK, Jung TY.
Case Reports of Tectal Plate Gliomas Showing Indolent Course
Brain Tumor Res Treat. 2020 Oct;8(2):109-112. doi: 10.14791/btrt.2020.8.e17.

2020. Kim SR, Kim HY, Nho JH, Ko E, Moon KS, Jung TY.
Relationship among symptoms, resilience, post-traumatic growth, and quality of life in patients with glioma
Eur J Oncol Nurs. 2020 Oct;48:101830. doi: 10.1016/j.ejon.2020.101830. Epub 2020 Sep 12.

2020. Tran TA, Kim YH, Duong TH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY.
Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model
Front Immunol. 2020 Jun 11;11:1165. doi: 10.3389/fimmu.2020.01165. eCollection 2020.

2020. Kim JK, Jung TY, Jung S, Kim IY, Jang WY, Moon KS, Kim SK, Kim JH, Lee KH: Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma. Clin Transl Oncol. Jul 2, 2020

2020. Tran TA, Kim YH, Duong TH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY: Peptide vaccine combined adjuvants modulate anti-tumor effects of radiation in glioblastoma mouse model. Front Immunol. 11:1165, 2020

2020. Kim YH, Tran TA, Duong TH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY: Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1. Hum Vaccin Immunother. 16(11):2840-2848, 2020

2018. Jung JH, Chai YH, Jung S, Kim IY, Jang WY, Moon KS, Kim SK, Chong S, Kim SK, Jung TY.
Visual outcome after endoscopic third ventriculostomy for hydrocephalus
Childs Nerv Syst. 2018 Feb;34(2):247-255. doi: 10.1007/s00381-017-3626-4. Epub 2017 Nov 3.

2018. Cheon YJ, Jung TY, Jung S, Kim IY, Moon KS, Lim SH: Efficacy of gamma knife radiosurgery for recurrent high-grade gliomas with limited tumor volume. J Korean Neurosurg Soc. 61(4):516-524, 2018

2018. Jung JH, Chai YH, Jung S, Kim IY, Jang WY, Moon KS, Kim SK, Chong S, Kim SK, Jung TY: Visual outcome after endoscopic third ventriculostomy for hydrocephalus. Childs Nerv Syst. 34(2):247-255, 2018

2017. Chai YH, Jung S, Lee JK, Kim IY, Jang WY, Moon KS, Kim JH, Lee KH, Kim SK, Jung TY.
Ependymomas: Prognostic Factors and Outcome Analysis in a Retrospective Series of 33 Patients
Brain Tumor Res Treat. 2017 Oct;5(2):70-76. doi: 10.14791/btrt.2017.5.2.70. Epub 2017 Oct 31.

2017. Kim JH, Jung TY, Hwang EC, Jung SH, Jung S, Kim IY, Jang WY, Moon KS, Lee KH, Kim SK: Disease progression patterns of bevacizumab responders with recurrent malignant gliomas. Oncol Lett. 14(3):3529-3535, 2017

2017. Jung TY, Kim IY, Lim SH, Park KS, Kim DY, Jung S, Moon KS, Jang WY, Kang SR, Cho SG, Min JJ, Bom HS, Kwon SY: Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake. EJNMMI Res. 7(1):45, 2017

2017. Jung TY, Min JJ, Bom HS, Jung S, Kim IY, Lim SH, Kim DY, Kwon SY: Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma. Neurosurg Rev. 40(2):223-229, 2017

2016. Kim YH, Tran TA, Lee HJ, Jung SI, Lee JJ, Jang WY, Moon KS, Kim IY, Jung S, Jung TY.
Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99
Oncotarget. 2016 Aug 2;7(31):50535-50547. doi: 10.18632/oncotarget.10495.

2016. Hwang EC, Yu SH, Jo YH, Jung SI, Kang TW, Kwon DD, Choi C, Heo SH, Hwang JE, Jung SH, Jung TY.
Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy
Asian J Androl. 2016 Jan-Feb;18(1):54-9. doi: 10.4103/1008-682X.154317.

2016. Kim YH, Tran TA, Lee HJ, Jung SI, Lee JJ, Jang WY, Moon KS, Kim IY, Jung S, Jung TY: Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99. Oncotarget 2;7(31):50535-50547, 2016

2015. Han HH, Ko WJ, Yoo TK, Oh TH, Kim DY, Kwon DD, Byun SS, Kim SI, Jung TY.
Reply by the authors
Urology. 2015 Jan;85(1):275-6. doi: 10.1016/j.urology.2014.09.011.

2015. Jung TY, Lee JY, Kim DS, Park HJ, Kim CY, Ra YS, Lee MJ, Kim SH, Baek HJ, Kim IH, Park KD, Kim SK: Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology. J Neurooncol 121(2):413-9, 2015

2014. Han HH, Ko WJ, Yoo TK, Oh TH, Kim DY, Kwon DD, Byun SS, Kim SI, Jung TY.
Factors associated with continuing medical therapy after transurethral resection of prostate
Urology. 2014 Sep;84(3):675-80. doi: 10.1016/j.urology.2014.04.027. Epub 2014 Jul 22.

2014. Jung TY, Kim IY, Jung S, Jang WY, Moon KS, Park SJ, Lim SH. Alterative treatment of stereotactic cyst aspiration and radiosurgery for cystic brain metastases. Stereotact Funct Neurosurg 92(4):234-41, 2014

2013. Jung TY, Choi YD, Kim YH, Lee JJ, Kim HS, Kim JS, Kim SK, Jung S, Cho D. Immunological characterization of glioblastoma cells for immunotherapy. Anticancer Res 33(6):2525-33, 2013

2012. Pei J, Jung S, Jin SG, Moon KS, Wen M, Li SY, Jang WY, Ryu HH, Lee KH, Kim IY, Jung TY.
Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas
Acta Neurochir (Wien). 2012 Apr;154(4):611-20; discussion 620. doi: 10.1007/s00701-012-1289-1. Epub 2012 Feb 11.

2012. Jung TY, Jung S, Kim IY, Moon KS, Jang WY, Park SJ, Kim YH, Kim HS, Min JJ, Kim J. Pathologic analysis of glioblastoma via multiple multiple stereotaxic biopsies of active tumor or necrosis. Oncol Rep 27(3):707-13, 2012

2011. Choi KY, Jung TY, Jung S, Kim YH, Moon KS, Kim IY, Kang SS, Lee KH. Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion. J Neurooncol 103:103-110, 2011. 5

2010. Jung TY, Pham TN, Umeyama A, Shoji N, Hashimoto T, Lee JJ, Takei M. Ursolic acid isolated from Uncaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ Naive T cells. Eur J Pharmacol 25:643(2-3):297-303, 2010

2010. Jung TY, Jung S, Moon KS, Kim IY, Kang SS, Kim YH, Park CS, Lee KH. Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma. Oncol Rep 23(5):1269-76, 2010

2009. Jung TY, Jung S, Choi JE, Moon KS, Kim IY, Kang SS: Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation. J Neurosurg 111(3):572-7, 2009

2009. Cao VT, Jung TY, Jung S, Jin SG, Moon KS, Kim IY, Kang SS, Park CS, Lee KH, Chae HJ: The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery 65(5):866-75, 2009

2008. Jung TY, Jung S, Ryu HH, Jeong YI, Jin YH, Jin SG, Kim IY, Kang SS, Kim HS: Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines J Neurosurg 109(2):273-84,2008

그 외 SCI(E) 논문 120편

펼쳐보기

저서

2012
Jung TY, JT Rutka. Posterior fossa tumors in the pediatric population: multidisciplinary management. Schimidek and Sweet operative neurosurgical techniques. 2012

펼쳐보기

특허

2017 미국특허 : 브랜치트 멀티펩티드 조성물 및 이를 포함하는 백신

펼쳐보기

학회활동

대한신경외과학회 정회원

대한뇌종양학회 정회원 / 상임이사

대한소아신경외과학회 정회원 / 상임이사

대한신경종양학회 정회원 / 교육수련이사

대한소아뇌종양학회 정회원 / 총무이사

대한신경외과학회 여의사회 학술이사

펼쳐보기

언론보도

2014 여의열전 : 뇌종양 수술 연구 차세대 주자 - 화순전남대학교병원 신경외과 정태영 교수 / 경향신문 / 2014-03-06

펼쳐보기